Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

ASCO: Combo Regimen Effective in CLL With Coexisting Conditions

drugsJune 05, 2019

Tag: ASCO , CLL , Venetoclax , obinutuzumab

PharmaSources Customer Service